| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |